Cargando…

Molecular Targeted Intervention for Pancreatic Cancer

Pancreatic cancer (PC) remains one of the worst cancers, with almost uniform lethality. PC risk is associated with westernized diet, tobacco, alcohol, obesity, chronic pancreatitis, and family history of pancreatic cancer. New targeted agents and the use of various therapeutic combinations have yet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohammed, Altaf, Janakiram, Naveena B., Pant, Shubham, Rao, Chinthalapally V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586783/ https://www.ncbi.nlm.nih.gov/pubmed/26266422 http://dx.doi.org/10.3390/cancers7030850

Ejemplares similares

Sea Cucumbers Metabolites as Potent Anti-Cancer Agents
por: Janakiram, Naveena B., et al.
Publicado: (2015)

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma
por: Rao, Chinthalapally V., et al.
Publicado: (2015)

Targeting pancreatitis blocks tumor-initiating stem cells and pancreatic cancer progression
por: Mohammed, Altaf, et al.
Publicado: (2015)

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
por: Mohammed, Altaf, et al.
Publicado: (2017)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer
por: Janakiram, Naveena B., et al.
Publicado: (2016)

Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives
por: Mohammed, Altaf, et al.
Publicado: (2018)

Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
por: Yarla, Nagendra S., et al.
Publicado: (2020)

Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling
por: Guruswamy, Suresh, et al.
Publicado: (2008)

Biological effects and epidemiological consequences of arsenic exposure, and reagents that can ameliorate arsenic damage in vivo
por: Rao, Chinthalapally V., et al.
Publicado: (2017)

The Role of the Inflammatory Response in Mediating Functional Recovery Following Composite Tissue Injuries
por: Janakiram, Naveena B., et al.
Publicado: (2021)

Efficacy of non-surgical interventions for promoting improved functional outcomes following acute compartment syndrome: A systematic review
por: Janakiram, Naveena B., et al.
Publicado: (2022)

Development of a dietary formulation of the SHetA2 chemoprevention drug for mice
por: Benbrook, Doris M., et al.
Publicado: (2017)

“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
por: Rao, Chinthalapally V., et al.
Publicado: (2020)

Early and delayed intervention with Rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice
por: PATLOLLA, JAGAN M.R., et al.
Publicado: (2015)

Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice
por: Kumar, Gaurav, et al.
Publicado: (2021)

Targeting KRAS in Pancreatic Cancer
por: Cowzer, Darren, et al.
Publicado: (2022)

Neural Regulation of Pancreatic Cancer: A Novel Target for Intervention
por: Chang, Aeson, et al.
Publicado: (2015)

Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer
por: Guo, Junli, et al.
Publicado: (2016)

The Galectin Family as Molecular Targets: Hopes for Defeating Pancreatic Cancer
por: Manero-Rupérez, Noemí, et al.
Publicado: (2020)

Importance of Diet Modification in Preventing Recurrent Episodes of Hypertriglyceridemic Pancreatitis (HTGP)
por: Janakiram, Nikhila
Publicado: (2021)

Pancreatic Cancer Gene Therapy: From Molecular Targets to Delivery Systems
por: Fillat, Cristina, et al.
Publicado: (2011)

Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer
por: Jugniot, Natacha, et al.
Publicado: (2020)

Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management
por: Rahman, Md. Ataur, et al.
Publicado: (2022)

Targeting IL-23 for the interception of obesity-associated colorectal cancer
por: Madka, Venkateshwar, et al.
Publicado: (2023)

Genomic Instability and Colon Carcinogenesis: From the Perspective of Genes
por: Rao, Chinthalapally V., et al.
Publicado: (2013)

How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
por: Rao, Chinthalapally V., et al.
Publicado: (2021)

Common Risk Factor Approach to Limit Noncommunicable Diseases and Periodontal Disease—The Molecular and Cellular Basis: A Narrative Review
por: Puzhankara, Lakshmi, et al.
Publicado: (2021)

Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
por: Jose, Anmi, et al.
Publicado: (2020)

The role of molecular testing in pancreatic cancer
por: Zhen, David B., et al.
Publicado: (2023)

The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
por: Yin, Chao, et al.
Publicado: (2022)

Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges
por: Kumar, Naveena A. N., et al.
Publicado: (2021)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
por: Qian, Yunzhen, et al.
Publicado: (2020)

Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets
por: Maharjan, Chandra K., et al.
Publicado: (2021)

Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
por: Sureban, Sripathi M., et al.
Publicado: (2013)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
por: Pant, Shubham, et al.
Publicado: (2008)

Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer
por: Jin, Guihua, et al.
Publicado: (2020)

Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer
por: Huang, Can, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n6gsur0sl32cuqgv1q6peeetv2